Personalized medication testing for people with schizophrenia
Part of Mental health clinical trials.
This study uses genetic testing plus careful monitoring of medication levels to help adjust antipsychotic treatment for schizophrenia. It may help improve symptoms and reduce side effects by choosing the most suitable medication dose or option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old
- You have a diagnosis of schizophrenia
- Your psychiatrist needs to change your antipsychotic medicine because symptoms, side effects, or taking the medicine is not going well
- You will be prescribed at least one of these: aripiprazole, olanzapine, paliperidone, quetiapine, risperidone, or amisulpride
- If you can become pregnant, you agree to use very effective birth control during the study
- You cannot be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether using a genetic test (pharmacogenomics) can help doctors choose the right antipsychotic medication for people with schizophrenia whose current treatment is not working well or causes side effects. The goal is to find a better medicine match for you.
This study tests if using genetic information can help doctors choose the right mental health medication or dose. It may help find treatments that work better with fewer side effects.
This study compares a personalized medication plan based on your genes versus standard dosing for people with depression, anxiety, or psychosis. It may help your clinician choose a safer or more effective dose or medicine by using pharmacogenomics (gene-informed prescribing).
This study tests whether using brain scans and genetic tests can help choose the best treatment for people early in their schizophrenia. It will check if these biomarkers can predict who will respond better to medication.
This study looks at whether a person’s genetic makeup can help choose safer medicines or improve how well treatment works. You may be asked for testing if you’ve had a bad reaction or treatment failure, or if you’re starting a new medicine that is known to be affected by genetics.
This study is developing more personalized treatments for schizophrenia, depression, or bipolar disorder. It may help find the best treatment approach for your specific situation.
Hear when a new Patients With Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.